An additional link emerges from increased glycogen synthase kinase 3 (GSK3β) in AD, resulting in a non-characteristic APP processing, leading to an elevated Aβ production and hyperphosphorylated tau [149]. The gene discussed is GSK3B; the disease is Alzheimer disease.